Skip to content
Open access

Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data

Nov 2026 · Alcohol, clinical & experimental research · Vol 50 · 0 citations · 26 references
Medicine

Abstract

ABSTRACT Background Alcohol‐associated liver disease (ALD) is a leading indication for liver transplantation (LT) in the United States. While post‐transplant outcomes are well established, the relative survival benefit of LT compared to non‐LT remains underdefined. Methods Using Optum's de‐identified Clinformatics Data Mart Database, we identified adults with ALD between 2017 and 2024. We used logistic regression to evaluate factors associated with LT, and Cox regression to compare survival between LT recipients and non‐recipients. Results Among 373,025 patients with ALD, 3453 underwent LT. Female sex (adjusted OR = 0.805; 95% Confidence Interval (CI): 0.750–0.866), African‐American race (adjusted OR = 0.542; 95% CI: 0.462–0.636), older age, and non‐liver comorbidities, and all types of metastatic cancer were associated with lower odds of LT; non‐metastatic liver cancer, however, was associated with increased odds of LT (adjusted OR = 4.147; 95% CI: 3.659–4.699). The 8‐year restricted mean survival time was 2600 days (~7.12 years) for LT recipients and 1799 days (~4.93 years) for nonrecipients. The median survival among deceased patients was 1000 days with LT vs. 355 days without LT. LT was associated with a lower adjusted mortality risk (HR, 0.365; 95% CI: 0.333–0.401). Conclusion LT confers a substantial survival advantage for patients with ALD, beyond what is achieved without transplantation. However, significant sex and race‐based disparities persist, underscoring the need for policy interventions to promote equitable access and optimized candidate selection.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.